FindMyKOL
Clinical trialNCT04359186RecruitingInterventional

SCOPE Analytic Treatment Interruption Protocol

NCT04359186 is an interventional trial sponsored by University of California, San Francisco. As of 21 Nov 2026, it is recruiting participants. It studies HIV/AIDS. The registry lists an enrollment of 40 participants at 1 site in 1 country. The registry lists a start date of 15 Oct 2020 and a primary completion date of 31 Dec 2027. One of its registered investigators has a FindMyKOL profile.

View the registry record on ClinicalTrials.gov

Key facts

Registry attributes as recorded on the ClinicalTrials.gov study record.

Key facts for NCT04359186
FieldValue
Registry IDNCT04359186
StatusRecruiting
Study typeInterventional trial
Lead sponsorUniversity of California, San Francisco
Enrollment40
Registered sites1
Countries1
ConditionsHIV/AIDS
Start15 Oct 2020
Primary completion31 Dec 2027
Study completion30 Jun 2028
Last update posted23 Jan 2026

Registered summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The goal of this study is to understand the interaction between HIV and the host at the earliest stages when HIV medications are paused. Volunteers with HIV will interrupt antiretroviral therapy (ART) and then have intensive studies preformed two to three times per week. Most will resume therapy within three weeks, even if the virus does not rebound during this time.

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

California, United States1 site, 1 recruiting
  • University of California San Francisco

    San Francisco

    Recruiting

United States, by state

AlaskaAKMaineMEVermontVTNew HampshireNHWashingtonWAMontanaMTNorth DakotaNDMinnesotaMNWisconsinWIMichiganMINew YorkNYMassachusettsMARhode IslandRIOregonORIdahoIDSouth DakotaSDIowaIAIllinoisILIndianaINOhioOHPennsylvaniaPANew JerseyNJConnecticutCTCalifornia: 1 site, 1 recruitingCA1NevadaNVWyomingWYNebraskaNEMissouriMOKentuckyKYWest VirginiaWVVirginiaVAMarylandMDDelawareDEArizonaAZUtahUTColoradoCOKansasKSArkansasARTennesseeTNNorth CarolinaNCSouth CarolinaSCNew MexicoNMOklahomaOKLouisianaLAMississippiMSAlabamaALGeorgiaGAHawaiiHITexasTXFloridaFLDistrict of ColumbiaDC
Fewer sitesMore sites

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Questions about NCT04359186

Each answer restates registry values shown on this page.

What is NCT04359186?

NCT04359186 is an interventional trial sponsored by University of California, San Francisco. It studies HIV/AIDS.

Is NCT04359186 recruiting?

As of 21 Nov 2026, it is recruiting participants. 1 of its 1 sites list their own status as recruiting.

Who leads NCT04359186?

The registry names Steven Deeks, MD (principal investigator, University of California, San Francisco) as the overall official.

Where does NCT04359186 run?

The registry lists 1 site in 1 country. Every site with a stated country is in one country: United States.

When is NCT04359186 expected to complete?

The registry lists a primary completion date of 31 Dec 2027 and a study completion date of 30 Jun 2028. The sponsor last updated the record on 23 Jan 2026.

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 21 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.